sulfamic acid has been researched along with estrone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Howarth, NM; Potter, BV; Purohit, A; Reed, MJ | 1 |
| Elger, W; Hedden, A; Reddersen, G; Schneider, B; Schwarz, S | 1 |
| Elger, W; Henkel, H; Richter, M; Schwarz, S; Thieme, I; Undeutsch, B | 1 |
| Barrow, D; Hejaz, HA; Nicholson, RI; Potter, BV; Purohit, A; Reed, MJ; Woo, LW | 1 |
| Ahmed, S; James, K; Owen, CP; Patel, CK; Patel, M | 2 |
| Casini, A; Montero, JL; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 1 |
| Fujii, T; Iwashita, S; Koizumi, N; Nakagawa, T; Okada, M; Takegawa, S | 1 |
| Liebl, R; von Angerer, E; Walter, G | 1 |
| Chander, SK; Potter, BV; Purohit, A; Reed, MJ; Woo, LW | 1 |
| Hejaz, HA; Leese, MP; Mahon, MF; Newman, SP; Potter, BV; Purohit, A; Reed, MJ | 1 |
| Potter, BV; Purohit, A; Woo, LW | 1 |
| Edwards, DR; Wolfenden, R | 1 |
| Potter, BV; Thomas, MP | 1 |
| Ali, H; Gémes, N; Mernyák, E; Minorics, R; Paragi, G; Resch, V; Szebeni, GJ; Traj, P; Zupkó, I | 1 |
1 review(s) available for sulfamic acid and estrone
| Article | Year |
|---|---|
Development of steroid sulfatase inhibitors.
Topics: Drug Design; Enzyme Inhibitors; Estrone; Humans; Steryl-Sulfatase; Sulfonic Acids | 2011 |
14 other study(ies) available for sulfamic acid and estrone
| Article | Year |
|---|---|
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
Topics: Breast Neoplasms; Cell Division; Drug Screening Assays, Antitumor; Estrone; Humans; Sulfatases; Sulfonic Acids; Tumor Cells, Cultured | 1994 |
Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
Topics: Administration, Oral; Angiotensin I; Animals; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Drug Evaluation, Preclinical; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Liver; Luteinizing Hormone; Organ Size; Ovariectomy; Prodrugs; Rats; Rats, Wistar; Sulfonic Acids; Uterus | 1995 |
Synthesis of estrogen sulfamates: compounds with a novel endocrinological profile.
Topics: Estradiol; Estriol; Estrogens; Estrone; Magnetic Resonance Spectroscopy; Sulfonic Acids | 1996 |
Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Coumarins; Enzyme Inhibitors; Estrogens; Estrone; Female; Humans; Kinetics; Oxepins; Rats; Rats, Wistar; Sulfatases; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured | 2001 |
Novel inhibitors of the enzyme estrone sulfatase (ES).
Topics: Alkanes; Coumarins; Enzyme Inhibitors; Estrone; Inhibitory Concentration 50; Ketones; Mesylates; Sulfatases; Sulfonamides; Sulfonic Acids | 2001 |
Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
Topics: Estrogens; Estrone; Inhibitory Concentration 50; Kinetics; Phenols; Structure-Activity Relationship; Sulfatases; Sulfonic Acids | 2001 |
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
Topics: Antigens, Neoplasm; Arylsulfatases; Biomarkers, Tumor; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Enzyme Inhibitors; Estrone; Humans; Membrane Proteins; Neoplasm Proteins; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids | 2003 |
Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrone; Female; Humans; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Uterus | 2003 |
2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Estrone; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Transcriptional Activation | 2004 |
The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.
Topics: Animals; Coumarins; Drug Combinations; Estrogens; Estrone; Female; Homeostasis; Organ Size; Ovariectomy; Rats; Rats, Wistar; Steryl-Sulfatase; Sulfonamides; Sulfonic Acids; Uterus | 2004 |
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Estradiol; Estrone; Female; Humans; Mice; Molecular Structure; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Transplantation, Heterologous | 2005 |
Proton-in-flight mechanism for the spontaneous hydrolysis of N-methyl O-phenyl sulfamate: implications for the design of steroid sulfatase inhibitors.
Topics: Arylsulfatases; Catalysis; Coumarins; Esters; Estrone; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Molecular Structure; Steryl-Sulfatase; Sulfonamides; Sulfonic Acids | 2012 |
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosis; Estrone; Female; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Steryl-Sulfatase; Sulfonic Acids; Tubulin Modulators | 2015 |
Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13α-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Estrone; Female; Human papillomavirus 16; Humans; Uterine Cervical Neoplasms | 2023 |